POAIPredictive Oncology Inc.

Nasdaq predictive-oncology.com


$ 0.94 $ 0.03 (3.67 %)    

Monday, 09-Sep-2024 14:29:36 EDT
QQQ $ 455.25 $ 5.77 (1.29 %)
DIA $ 409.08 $ 4.58 (1.13 %)
SPY $ 546.60 $ 6.05 (1.12 %)
TLT $ 99.96 $ 0.43 (0.43 %)
GLD $ 231.58 $ 0.97 (0.42 %)
$ 0.9486
$ 0.94
$ 0.89 x 300
-- x --
$ 0.94 - $ 0.94
$ 0.85 - $ 4.10
32,991
na
6.32M
$ 1.98
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 03-28-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-21-2023 12-31-2022 10-K
8 11-10-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-12-2022 03-31-2022 10-Q
11 03-31-2022 12-31-2021 10-K
12 11-10-2021 09-30-2021 10-Q
13 08-11-2021 06-30-2021 10-Q
14 05-12-2021 03-31-2021 10-Q
15 03-15-2021 12-31-2020 10-K
16 11-16-2020 09-30-2020 10-Q
17 08-13-2020 06-30-2020 10-Q
18 06-08-2020 03-31-2020 10-Q
19 04-01-2020 12-31-2019 10-K
20 11-15-2019 09-30-2019 10-Q
21 08-19-2019 06-30-2019 10-Q
22 05-15-2019 03-31-2019 10-Q
23 04-01-2019 12-31-2018 10-K
24 11-14-2018 09-30-2018 10-Q
25 08-14-2018 06-30-2018 10-Q
26 05-15-2018 03-31-2018 10-Q
27 04-02-2018 12-31-2017 10-K
28 11-14-2017 09-30-2017 10-Q
29 08-14-2017 06-30-2017 10-Q
30 05-15-2017 03-31-2017 10-Q
31 03-15-2017 12-31-2016 10-K
32 11-14-2016 09-30-2016 10-Q
33 08-12-2016 06-30-2016 10-Q
34 05-23-2016 03-31-2016 10-Q
35 03-16-2016 12-31-2015 10-K
36 11-13-2015 09-30-2015 10-Q
37 08-10-2015 06-30-2015 10-Q
38 05-18-2015 03-31-2015 10-Q
39 04-30-2015 12-31-2014 10-K
40 11-12-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-initiates-coverage-on-predictive-oncology-with-buy-rating-announces-price-target-of-3

HC Wainwright & Co. analyst Swayampakula Ramakanth initiates coverage on Predictive Oncology (NASDAQ:POAI) with a Buy ra...

 predictive-oncology-q2-eps-068-up-from-098-yoy-sales-27872k-down-from-49011k-yoy

Predictive Oncology (NASDAQ:POAI) reported quarterly losses of $(0.68) per share. This is a 30.61 percent increase over losses ...

 predictive-oncology-has-expanded-the-available-applications-for-its-platform-to-account-for-patient-heterogeneity-de-risk-drug-discovery-and-accelerate-pipeline-development

Findings demonstrate real-world applications of Company's AI platform to support biomarker discovery, clinical trial optimi...

 predictive-oncology-exercises-warrants-for-126m-gross-proceeds

Predictive Oncology Inc. (NASDAQ:POAI), a leader in AI-driven drug discovery and biologics, today announced that it has entered...

 why-predicitive-oncology-stock-is-soaring

Predictive Oncology shares are blasting higher Thursday after the company announced it is expanding its AI and machine learning...

 reported-earlier-predictive-oncology-enters-biomarker-discovery-market-after-successful-retrospective-ovarian-cancer-study-yields-compelling-results-expands-aiml-driven-offering-to-include-novel-oncology-biomarker-discovery-to-predict-patient-outcomes-and-drug-response-in-oncology

Expands AI/ML driven offering to include novel oncology biomarker discovery to predict patient outcomes and drug response in on...

Core News & Articles
Market-Moving News for July 25th
07/25/2024 13:01:55

EW: -24% | Edwards Lifesciences shares are trading lower after the company reported worse-than-expected Q2 sales results and is...

 predictive-oncology-introduces-new-technology-for-expressing-functional-and-stable-g-protein-coupled-receptors-gpcrs

Company files expansive intellectual property protection for "Membrane Protein Factory" to produce purified and biologi...

 why-predictive-oncology-poai-stock-is-skyrocketing

Predictive Oncology shares are trading higher by 46.6% during Tuesday's session. The company announced positive results fro...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION